GSK3844766A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3844766A, covering 2022-03-23 to 2022-03-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults [Phase 1, Phase 2]